newsfilter
← Latest News
GlobeNewswire·

Phio CEO to Speak at Wainwright Conference in New York in September

MARLBOROUGH, Mass., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Phio Pharmaceuticals (NASDAQ:PHIO), a clinical stage biotechnology company whose proprietary INTASYL™ RNAi platform technology is designed to make immune